Ponatinib

Ponatinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2372-5mg 5 mg - - -

5 - 10 business days*

34.00€
TGM-T2372-1mL 1 ml

5 - 10 business days*

46.00€
TGM-T2372-10mg 10 mg

5 - 10 business days*

46.00€
TGM-T2372-25mg 25 mg - - -

5 - 10 business days*

51.00€
TGM-T2372-50mg 50 mg

5 - 10 business days*

57.00€
TGM-T2372-100mg 100 mg

5 - 10 business days*

89.00€
TGM-T2372-500mg 500 mg - - -

5 - 10 business days*

208.00€
 
Description: Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor with IC50... more
Product information "Ponatinib"
Description: Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor with IC50 values of 0.37 nM (Abl), 1.1 nM (PDGFRalpha), 1.5 nM (VEGFR2), 2.2 nM (FGFR1), and 5.4 nM (Src). Target: PDGFR, Bcr-Abl, Autophagy, Src, VEGFR, c-Kit, FGFR. Smiles: C(#CC1=CC(C(NC2=CC(C(F)(F)F)=C(CN3CCN(C)CC3)C=C2)=O)=CC=C1C)C=4N5C(=NC4)C=CC=N5. References: O'Hare T, et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell. 2009 Nov 6,16(5):401-12.
Keywords: AP24534
Supplier: TargetMol
Supplier-Nr: T2372

Properties

MW: 532.56 D
Formula: C29H27F3N6O

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H301, H311, H331
P Phrases: P261, P264, P270, P271, P280, P301+310, P302+352, P304+340, P311, P312, P321, P330, P361+364, P403+233, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Ponatinib"
Write a review
or to review a product.
Viewed